18 OCTOBER 2017 |
||
HEMATOLOGY PROGRAM |
||
| 12.00 - 13.00 | LUNCH | |
| 13.00 - 13.15 | OPENING REMARKS - Birol Guvenç - Giuseppe Saglio | |
| SESSION I - HIGHLIGHTS IN HEMATOLOGY - PRESIDENTIAL SESSION | CHAIRS: Giuseppe Saglio, Şehmus Ertop, Serdar Bedii Omay | |
| 13.15 - 13.45 | Considerations After 15 years of Imatinib Therapy for CML: Lessons From the German Study IV | Rudiger Hehlmann |
| 13.45 - 14.15 |
Iron Overload in MDS and in Stem Cell Transplantatıon – Is it
An Issue? |
Eliezer Rachmilewitz |
| 14.15 - 14.45 |
Discordance Between Scientific Evidence and Hematologists
Practices: Do as I say, Not as I do |
Robert Gale |
| 14.45 - 15.15 | Cord Blood Transplant: Present Situation | Daniela Cilloni |
| 15.15 - 15.45 | COFFEE BREAK | |
| SESSION II - MULTIPLE MYELOMA - PROF. EKREM MÜFTÜOĞLU SESSION | CHAIRS: Evangelos Terpos, Zahit Bolaman, Orhan Ayyıldız | |
| 15.45 - 16.15 | First-Line Multiple Myeloma Therapy | Evangelos Terpos |
| 16.15 - 17.00 | Treatmens in Relapsed / Refractory Multiple Myeloma |
Meral Beksaç -  Satellite
|
| 17.00 - 17.30 | Novel Diagnostic and Response Criteria for Myeloma - the Role of MRD | Maria Gavriatopoulou |
| 17.30 - 18.00 | COFFEE BREAK | |
| SESSION III - ACUTE MYELOID LEUKEMIA - PROF. ATİLLA YALÇIN SESSION | CHAIRS: Charles Schiffer, Ferit Avcu, Düzgun Özatli | |
| 18.00 - 18.30 | Molecular Biology of AML | Mehmet Yılmaz |
| 18.30 - 19.00 | Induction Therapy For Hıgh-Risk AML | Charles Schiffer |
| 19.00 - 19.30 | Novel Therapies in AML | Fahrad Ravandi |
19 OCTOBER 2017 |
||
| 07.30 - 08.15 | MEET THE EXPERT: Elias Jabbour - AML, Guillermo Garcia Manero - MDS, Haifa Kathrin Al-Ali - MPNs | |
| SESSION IV - ACUTE LYMPHOID LEUKEMIAS | CHAIR: Dieter Hoelzer, Ali Ünal, Deniz Sargın | |
| 08.30 - 09.00 | The Essential Management of Adult ALL | Dieter Hoelzer |
| 09.00 - 09.30 | Diagnostic And Prognostic Markers in ALL | Alessandro Cignetti |
| 09.30 - 10.00 | Monoclonal Antibodies in ALL | Elias Jabbour |
| 10.00 - 10.30 | Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy? | Yes: Elias Jabbour |
| 10.30 - 11.00 | Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy? | No: Robin Foà |
| 11.00 - 11.30 | COFFEE BREAK | |
| SESSION V - MYELODYSPLASTIC SYNDROME | CHAIRS: Elias Jabbour, Levent Ündar, Osman İlhan | |
| 11.30 - 12.00 | Molecular Pathophysiology and Classification Of MDS | Mustafa Cetiner |
| 12.00 - 12.30 | How I Treat MDS | Guillermo Garcia Manero |
| 12.30 - 13.00 | New Therapies in MDS | Elias Jabbour |
| 13.00 - 14.00 | LUNCH | |
| SESSION VI - ANEMIAS | CHAIRS: Hanan Hamed, Sema Anak | |
| 14.00 - 14.30 | Management of Sickle Cell Disease | Charles Stark |
| 14.30 - 15.00 | New Drugs for Modulation the Erythropoiesis in Hemoglobinopathies | Antonio Piga |
| 15.00 - 15.30 | Paroxysmal Nocturnal Hemoglobinuria | Hanan Hamed |
| SESSION VII - CHRONIC MYELOID LEUKEMIAS | CHAIRS: Naeem Chaudhri, Rıdvan Ali | |
| 15.30 - 16.00 | History Of CML |
Birol Güvenç -  Satellite
|
| 16.00 - 16.30 | Management of CML in 2017 |
Rıdvan Ali - Satellite
|
| 16:30 - 17:00 | Chronic Myelogenous Leukemia Treatment Strategies | Giuseppe Saglio |
| 17.00 - 17.30 | Response Monitoring in Chronic Myeloid Leukemia in the TFR Era | Naeem Chaudhri |
| 17:30 - 18:00 | Treatment Discontinuation in Chronic Myeloid Leukemia, When and How ? | Carmen Fava |
| 18.00 - 18.30 | COFFEE BREAK | |
| SESSION VIII - CHRONIC MYELOPROLIFERATIVE DISORDERS | CHAIRS: Tariq Mughal, Güray Saydam | |
| 18.30 - 19.00 | Current Treatment of Myeloproliferative Neoplasms | Haifa Kathrin Al-Ali |
| 19.00 - 19.30 |
Jak2 Inhibıtors and What Comes Next for Patients with
BCR-ABL1- Negatıive Myeloproliferative Neoplasms |
Tariq Mughal |
| 19.30 - 20.30 | ORAL PRESENTATIONS | CHAIRS: Emin Kaya, Mahmut Töbü, Rauf Haznedar |
| POSTER WALK | CHAIRS: Ahmet İfran, Ahmet Öztürk, Mehmet Dağlı | |
20 OCTOBER 2017 |
||
| 07.30 - 08.15 | MEET THE EXPERT: Rudiger Hehlmann - CML, Charles Schiffer - AML, Carmino de Souza - NHLs | |
| SESSION IX - SPECIAL TOPICS FOR NHL | CHAIRS: Carmino de Souza, Burhan Ferhanoğlu | |
| 08.30 - 09.00 | Primary CNS Lymphoma; Chemo or Transplant for Young Patients? | Tayfur Toptaş |
| 09.00 - 09.30 | Chemoimmunotherapy or Chemo-Free Treatment for Follicular Lymphoma | Elif Birtaş Ateşoğlu |
| 09.30 - 10.00 | PD-1 Blockers in Relapsed Hodgkin Lymphoma and Problems of Bridging to Allo - Transplant | Huseyin Saffet Beköz |
| 10.00 - 10.30 | COFFEE BREAK | |
| SESSION X - AGGRESSIVE AND INDOLENT NH LYMPHOMAS | CHAIRS: Khalid Halahleh, Zafer Gülbaş | |
| 10.30 - 10.55 | Anaplastic Large Cell Lymphoma; Is It a Single Entity? Treatment Modalities? | Atilla Özkan |
| 10.55 - 11.20 | Transplant in NHL; When? To Whom? | Sevgi Kalayoglu Beşışık |
| 11.20 - 11.45 | Indolent Lymphomas: Practical Clinical Approach | Berksoy Şahin |
| 11:45 - 12:05 | Reference Biologics and Biosimilar Drugs | Mehmet Ali Özcan |
| 12.05 - 13.00 | LUNCH | |
| SESSION XI - CHRONIC LYMPHOCYTIC LEUKEMIAS | CHAIRS: Kostas Stamatopoulos , Salih Aksu | |
| 13.00 - 13.30 | Chronic Lymphocytic Leukemia: Biomarkers and Prognosis | Kostas Stamatopoulos |
| 13.30 - 14.00 | Chronic Lymphocytic Leukemia Old and New Treatments | Kostas Stamatopoulos |
| 14.00 - 14.30 | Peripheral T-Cell Lymphoma | Hanan Hamed |
| 14.30 - 15.00 | COFFEE BREAK | |
| SESSION XII - STEM CELL TRANSPLANT | CHAIRS: Carmino de Souza | |
| 15.00 - 15.25 |
Preparation and Detection of Biotin-Labeled Red Blood Cells
For Human Infusion |
Albert Donnenberg |
| 15.25 - 15.50 | Haploidentical Transplant | Zafer Gülbaş |
| 15.50 - 16.15 | Stem Cell Transplantation For Non-Hodgkin’s Lymphoma | Carmino de Souza |
| 16.15 - 16.40 | GVHD Pathophysiology and Treatment | Khalid Halahleh |
| 16.40 - 17.05 | From Allogenic Transplantation to Precision Immune Therapy: The Role of Effector Cells | Jean-Francois Rossi |
| 17.05 - 18.00 | ORAL PRESENTATIONS | CHAIRS: Gülsüm Özet, Yıldız Aydın, Pervin Topçuoğlu |
| POSTER WALK | CHAIRS: Oral Nevruz, Oktay Bilgir, Vahap Okan | |
21 OCTOBER 2017 |
||
| 08.30 - 09.15 | MEET THE EXPERT: Naeem Chaudhri - CML, Hanan Hamed -CLL, Tariq Mughal (Next Generation Sequencing for Hematologic Malignancies) | |
| SESSION XIII - COAGULATION AND INFECTIONS | CHAIRS: Giuseppe Saglio, Fahri Şahin | |
| 09.30 - 10.00 | D-dimer in the Diagnosis of Venous Thromboembolism | Pierre Toulon |
| 10.00 - 10.30 | Updates on Treatment in Hemophilia A and B | Bülent Antmen |
| 10.30 - 11.00 | Antifungal Management in Febril Neutropenia | Ömrum Uzun |
| 11.00 | CLOSING | |